(Q40142966)

English

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma

scientific article published on 13 August 2015

Statements

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma (English)
13 August 2015

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit